Advertisement

Psychological and Psychiatric Consequences of Amphetamines

  • Stephen A. Wyatt
  • Douglas Ziedonis
Chapter

Abstract

“Speed Freak,” a name for chronic and high-dose amphetamine abusers made popular in the late 1960s was a result of the bizarre behavior they often displayed. The amphetamine abuser may develop symptoms of anxiety, hypervigilance, impaired judgment, and psychosis. Psychotic behavior resulting from chronic amphetamine use has been examined in the scientific literature for decades. In 1938, the first of these reports discussed the link between psychotic behavior and the use of amphetamines in the treatment of narcolepsy (Young & Scoville, 1938). “Speed kills,” a phrase that originated in the early 1970s, refers to the lethal physical maladies or bizarrely morbid behavior associated with excessive and repeated use of amphetamines. This behavior was characterized by profound persecutory delusions, ideas of reference, and hallucinatory effects. It was during this time that the intravenous administration of large doses of amphetamines became increasingly prevalent. Similar behavior continues to be seen in association with both intravenous and the increasing popular inhaled misuse of this drug.

Keywords

Attention Deficit Disorder Psychiatric Consequence Persecutive Delusion Magnesium Pemoline Primary Mental Illness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders ( 4th ed. ). Washington, DC: Author.Google Scholar
  2. Angrist, B., Rotrosen, J., & Gershon, S. (1980). Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology, 72, 17–19.PubMedCrossRefGoogle Scholar
  3. Angrist, B., D’Hollosy, M., Sanfilipo, M., Satriano, J., Diamond, G., Simberkoff, M., & Weinred, H. (1992). Central nervous system stimulants as symptomatic treatment of AIDS-related neuropsychiatrie impairment. Journal of Clinical Psychopharmacology, 2, 268–273.Google Scholar
  4. Beninger, R. J., & Hahn, B. L. (1983). Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science, 220, 1304–1306.PubMedCrossRefGoogle Scholar
  5. Bowers, M. B. (1972). Acute psychosis induced by psychotomimetic drug abuse. Clinical findings. Archives of General Psychiatry, 27, 437–440.PubMedCrossRefGoogle Scholar
  6. Breakey, W. R., Goodell, H., Lorenz, P, & McHugh, P. (1974). Hallucinogenic drugs as precipitants of schizophrenia. Psychological Medicine, 4, 255–261.PubMedCrossRefGoogle Scholar
  7. Brien, R. L., Kleiman, J., & Eisenman R. (1972). Personality and drug use: Heroin, alcohol, methadrine, mixed drug dependency and the 16PF. Corrective Psychiatry and Journal of Social Therapy, 18, 22–23.Google Scholar
  8. Campbell, B. K., & Stark, J. M. (1990). Psychopathology and personality characteristics in different forms of substance abuse. International Journal of the Addictions, 25, 1467–1474.PubMedGoogle Scholar
  9. Cesarec, Z., & Nyman, A. K. (1985). Differential response to amphetamine in schizophrenia. Acta Psychiatrica Scandinavica, 71, 523–538.PubMedCrossRefGoogle Scholar
  10. Chiarello, R. J., & Cole, J. O. (1987). The use of psycho-stimulants in general psychiatry. Archives of General Psychiatry, 44, 286–295.PubMedCrossRefGoogle Scholar
  11. Churchill, A. C., Burgess, P., Pead, J., & Gill, T. (1993). Measurement of the severity of amphetamine dependence. Addiction, 88, 1335–1340.PubMedCrossRefGoogle Scholar
  12. Cohen, S. (1975). Amphetamine abuse. Journal of the American Medical Association, 213, 414–415.CrossRefGoogle Scholar
  13. Collins, J. P., Lesse, H., & Dagan, L. (1979). Behavioral antecedents of cocaine-induced stereotypy. Pharmacology, Biochemistry and Behavior, 11, 683–687.CrossRefGoogle Scholar
  14. Connell, P. H. (1958). Amphetamine psychosis (Maudsley Monograph No. 5 ). London: Chapman and Hall.Google Scholar
  15. Council on Scientific Affairs of the AMA. (1978). Clinical aspects of amphetamine abuse. Journal of the American Medical Association, 240, 2317.CrossRefGoogle Scholar
  16. Crockett, R., & Marks, V. (1969). Amphetamine taking among young offenders. British Journal of Psychiatry, 115, 1203–1204.CrossRefGoogle Scholar
  17. Davidoff, E., & Reifenstein, E. C. (1939). The results of eighteen months of benzedrine sulfate therapy in psychiatry. American Journal of Psychiatry, 95, 945–970.Google Scholar
  18. Davis, J. (1970). The effects of haloperido1 and chlorpromazine on amphetamine metabolism and amphetamine stereotyped behavior in rats. Journal of Pharmacology and Experimental Therapeutics, 174, 428–433.PubMedGoogle Scholar
  19. Elkins, R. N., Rapoport, J., Zahn, T., Buchsbaum, M., Weingartner, H., Kopin, I., Langer, D., & Johnson, C. (1981). Acute effects of caffeine in normal prepubertal boys. American Journal of Psychiatry, 138, 178–183.Google Scholar
  20. Ellinwood, E. H., Sudilovsky, A., & Nelson, L. (1973). Evolving behavior in the clinical and experimental amphetamine (model) psychosis. American Journal of Psychiatry, 130, 1088–1093.PubMedGoogle Scholar
  21. Ellison, G. D., & Eison, M.S. (1983). Continuous amphetamine intoxication: An animal model of the acute psychotic episode. Psychological Medicine, 13, 751–762.PubMedCrossRefGoogle Scholar
  22. Estroff, T. W., Dackis, C., Gold, M., & Pottash, A. (1985–1986). Drug abuse and bipolar disorders. International Journal of Psychiatry in Medicine, 15, 3740.Google Scholar
  23. Fischman, M. W, Schuster, C., Resnekov, L., Shick, J., Krasneger, N., Fennell, W, & Freedman, D. (1976). Cardiovascular and subjective effects of intravenous cocaine administration in humans. Archives of General Psychiatry, 33, 938–989.CrossRefGoogle Scholar
  24. Fischman, M. W., Schuster, C., Javaid, J., Hatano, Y., & Davis, J. (1985). Acute tolerance development to the cardiovascular and subjective effects of cocaine. Journal of Pharmacology and Experimental Therapeutics, 235, 677–682.PubMedGoogle Scholar
  25. Fukushima, A. (1994). Criminal responsibility in amphetamine psychosis. Japanese Journal of Psychiatry and Neurology, 48, 1–4.Google Scholar
  26. Galanter, M., & Ricardo, C. (1988). Substance abuse among general psychiatric patients: Place of presentation, diagnosis, and treatment. American Journal of Drug and Alcohol Abuse, 14, 211–235.PubMedCrossRefGoogle Scholar
  27. Gawin, E H. (1991). Cocaine addiction: Psychology and neurophysiology. Science, 251, 1580–1586.PubMedCrossRefGoogle Scholar
  28. Goeders, N. E., Dworkin, S., & Smith, J. (1986). Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex. Pharmacology, Biochemistry and Behavior, 24, 1429–1440.CrossRefGoogle Scholar
  29. Grinspoon, L., & Hedblom, P. (1975). The speed culture. Cambridge, MA: Harvard University Press.Google Scholar
  30. Gunne, E., & Lewander, T. (1967). Long-term effects of some dependence-producing drugs on the brain monoamines. In O. Wahaas (Ed.), Molecular basis of some aspects of mental activity (pp. 75–81 ). New York: Academic Press.Google Scholar
  31. Harris, G. C., & Wilhams, J. T. (1992). Sensitization of Locus ceruleus neurons during withdrawal from chronic stimulants and antidepressants. Journal of Pharmacology and Experimental Therapeutics, 261, 476–483.PubMedGoogle Scholar
  32. Hawks, D., Mitcheson, M., Ogborne, A., & Edwards, G. (1969). Abuse of methylamphetamine. British Medical Journal, 2, 715–721.PubMedCrossRefGoogle Scholar
  33. Hensala, J. D., Epstein, L., & Blacker, K. (1967). LSD and psychiatric inpatients. Archives of General Psychiatry, 16, 554–559.PubMedCrossRefGoogle Scholar
  34. Holmes, V. E (1995). Medical use ofpsychostimulants: An overview. International Journal of Psychiatry in Medicine, 25, 1–19.PubMedCrossRefGoogle Scholar
  35. Jaffe, J. H. (1985). Drug addiction and drug abuse. In L. S. Goodman, A. C. Gilman, & A. Gilman (Eds.), The pharmacological basis of therapeutics (7th ed., pp, 532–581 ). New York: Macmillan.Google Scholar
  36. Johanson, C. E., Balster, R., & Bonese, K. (1976). Self-administration of psychomotor stimulant drugs: The effects of unlimited access. Pharmacology, Biochemistry and Behavior, 4, 45–51.CrossRefGoogle Scholar
  37. Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders. American Journal of Psychiatry, 142, 1259–1264.PubMedGoogle Scholar
  38. King, G. R., & Ellinwood, E. H. (1992). Amphetamines and other stimulants. In J. H. Lowinson, P. Ruiz, R. D. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook ( 2nd ed., pp. 247–270 ). Baltimore: Williams & Wilkins.Google Scholar
  39. Kramer, J. C., Fischman, V., & Littlefield, D. (1967). Amphetamine abuse: Pattern and effects of high doses taken intravenously. Journal of the American Medical Association, 201, 89–93.CrossRefGoogle Scholar
  40. Lieberman, J. A., Kinon, B., & Loebel, A. (1990). Dopaminergic mechanisms in idiopathic and drug induced psychoses. Schizophrenia Bulletin, 16, 97–110.PubMedCrossRefGoogle Scholar
  41. Lyness, W. H., Friedle, N., & Moore, K. (1979). Destruction of dopaminergic nerve terminals in nucleus accumbens: Effects on d-amphetamine self-administration. Pharmacology, Biochemistry and Behavior, 11, 553–556.CrossRefGoogle Scholar
  42. McLellan, A. T., & Druley, K. A. (1977). Non-random relation between drugs of abuse and psychiatric diagnosis. Journal of Psychiatric Research, 13, 179–184.PubMedCrossRefGoogle Scholar
  43. McLellan, A. T., Woody, G. E., & O’Brien, C. P. (1979). Development of psychiatric illness in drug abusers. New England Journal of Medicine, 301, 1310–1314.CrossRefGoogle Scholar
  44. Mesulam, M. M. (1986). Frontal cortex and behavior. Annals of Neurology, 19, 320–325.PubMedCrossRefGoogle Scholar
  45. Mueser, K. T., Yarnold, P., Levinson, D., Singh, H., Bel-lack, A., Kee, K., Morrison, R., & Yadalem, K. (1990). Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophrenia Bulletin, 16, 31–54.PubMedCrossRefGoogle Scholar
  46. Mueser, K. T., Bellack, A. S., & Blanchard, J. J. (1992). Comorbidity of schizophrenia and substance abuse: Implications for treatment. Journal of Consultation in Clinical Psychology, 60, 845–856.CrossRefGoogle Scholar
  47. Nehlig, A., Lucignani, G., Kadekaro, M., Porrino, L., & Sokoloff, L. (1984). Effects of acute administration of caffeine on focal glucose utilization in the rat. European Journal of Pharmacology, 101, 91–100.PubMedCrossRefGoogle Scholar
  48. Physicians desk reference, 51st edition (pp. 2361–2363). (1995). Montvale, NJ: Medical Economics Data Production.Google Scholar
  49. Regier, M. E., Farmer, M. E., Rae, D. S., Laocke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association, 264, 2511–2518.PubMedCrossRefGoogle Scholar
  50. Reith, M. E., Benuck, M., & Lajtha, A. (1987). Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. Journal of Pharmacology and Experimental Therapeutics, 143, 281–287.Google Scholar
  51. Roberts, D. C., & Kobb, G. E. (1982). Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacology, Biochemistry and Behavior, 17, 901–904.CrossRefGoogle Scholar
  52. Rockwell, D. A., & Ostwald, P. (1968). Amphetamine use and abuse in psychiatric patients. Archives of General Psychiatry, 18, 612–616.PubMedCrossRefGoogle Scholar
  53. Rossetti, Z. L., Hmaidan, Y., & Gessa, G. L. (1992). Marked inhibition of Mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. European Journal of Pharmacology, 221, 227–234.PubMedCrossRefGoogle Scholar
  54. Sato, M. (1990). A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Annals of the New York Academy of Sciences, 654, 160–170.CrossRefGoogle Scholar
  55. Sato, M., Chen, C., Akiyama, K., & Otsuki, S. (1983). Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biological Psychiatry, 18, 429–440.PubMedGoogle Scholar
  56. Scheel-Kruger, J., Braestrup, C., Nielson, M., Golembiowska, K., & Mogilnicka, E. (1977). Cocaine: Discussion on the role of dopamine in the biochemical mechanism of action. In E. H. Ellinwood & M. M. Kilbey (Eds.), Cocaine and other stimulants (pp. 373–408 ). New York: Plenum.CrossRefGoogle Scholar
  57. Schneier, E. R., & Siris, S. G. (1987). A review of psychoactive substance use and abuse in schizophrenia: Patterns of drug choice. Journal of Nervous and Mental Disorders, 175, 641–652.CrossRefGoogle Scholar
  58. Schuckit, M. A. (1989). Drug and alcohol abuse: A clinical guide to diagnosis and treatment ( 3rd ed. ). New York: Plenum Medical Book Company.Google Scholar
  59. Seiden, L. S., Commin, D., Vosmer, G., Axt, K., & Marek, G. (1988). Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: A regional analysis in nigrostriatal and mesolimbic projections. Annals of the New York Academy of Sciences, 537, 161–172.PubMedCrossRefGoogle Scholar
  60. Sonsalla, P. K., Nicklas, W, & Heikkila, R. (1989). Role for excitatory amino acids in methamphetamine-induced nigrostriataodopaminergic toxicity. Science, 243, 398–400.PubMedCrossRefGoogle Scholar
  61. Spotts, J. V, & Shontz, F. C. (1991). Drugs and personality: Comparison of drug users, nonusers, and other clinical groups on the 16PF. International Journal of the Addictions, 26, 1019–1054.PubMedGoogle Scholar
  62. Weiss, R. D., Pope, H., & Mirin, S. (1985). Treatment of chronic cocaine abuse and Attention Deficit Disorder Residual Type with magnesium pemoline. Drug and Alcohol Dependence, 15, 9–72.CrossRefGoogle Scholar
  63. Weiss, R. D, Mirin, S., Michael, J., & Sollogub, A. (1986). Psychopathology in chronic cocaine users. American Journal of Drug and Alcohol Abuse, 12, 17–29.PubMedCrossRefGoogle Scholar
  64. Weiss, S. R., Post, R. M., Pert, A., Woodward, R., & Mur-man, D. (1989). Context-dependent cocaine sensitization: Differential effect of haloperidol on development versus expression. Pharmacology, Biochemistry and Behavior, 34, 655–661.Google Scholar
  65. Wise, S. P. (1985). The primate premotor cortex: Past, present, and preparatory. Annual Review of Neuroscience, 8, 1–19.PubMedCrossRefGoogle Scholar
  66. Yesavage, J. A., & Zarcone, V (1983). History of drug abuse and dangerous behavior in inpatient schizophrenics. Journal of Clinical Psychiatry, 44, 259–261.PubMedGoogle Scholar
  67. Young, D., & Scoville, W. B. (1938). Paranoid psychosis in narcolepsy and the possible dangers of benzedrine treatment. Medical Clinics of North America, 22, 637–645.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Stephen A. Wyatt
    • 1
  • Douglas Ziedonis
    • 1
  1. 1.Department of PsychiatryYale University School of MedicineNew HavenUSA

Personalised recommendations